| 1 |
34758617 | Long-Chain Acylcholines Link Butyrylcholinesterase to Regulation of Non-neuronal Cholinergic Signaling. | 2022 Mar 4 |
3 |
| 2 |
35090939 | Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach. | 2022 Apr 1 |
2 |
| 3 |
35623095 | Butyrylcholinesterase inhibitors as potential anti-Alzheimer's agents: an updated patent review (2018-present). | 2022 May 27 |
4 |
| 4 |
32520690 | Spiro Heterocyclic Compounds as Potential Anti-Alzheimer Agents (Part 2): Their Metal Chelation Capacity, POM Analyses and DFT Studies. | 2021 |
1 |
| 5 |
32746727 | The impact of some phenolic compounds on serum acetylcholinesterase: kinetic analysis of an enzyme/inhibitor interaction and molecular docking study. | 2021 Oct |
1 |
| 6 |
33103262 | Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism. | 2021 Mar |
1 |
| 7 |
33317802 | Perioperative use of physostigmine to reduce opioid consumption and peri-incisional hyperalgesia: a randomised controlled trial. | 2021 Mar |
1 |
| 8 |
33477276 | Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches. | 2021 Jan 17 |
2 |
| 9 |
33607363 | Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies. | 2021 Apr |
2 |
| 10 |
33670778 | The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis. | 2021 Feb 18 |
2 |
| 11 |
33735482 | Rhythmogenic networks are potently modulated by activation of muscarinic acetylcholine receptors in the rodent spinal cord. | 2021 Sep |
1 |
| 12 |
33804719 | Quinuclidine-Based Carbamates as Potential CNS Active Compounds. | 2021 Mar 20 |
1 |
| 13 |
33973470 | Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection. | 2021 May 27 |
4 |
| 14 |
34030906 | Cholinergic crisis caused by ingesting topical carpronium chloride solution: A case report. | 2021 Dec |
1 |
| 15 |
34208297 | Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity. | 2021 Jun 11 |
1 |
| 16 |
34269114 | Identification of Compounds for Butyrylcholinesterase Inhibition. | 2021 Dec |
2 |
| 17 |
34540646 | Adjuvant Drugs for Peripheral Nerve Blocks: The Role of NMDA Antagonists, Neostigmine, Epinephrine, and Sodium Bicarbonate. | 2021 Jun |
2 |
| 18 |
34719648 | A Novel Function of Sphingosylphosphorylcholine on the Inhibitory Effects of Acetylcholinesterase Activity. | 2021 |
5 |
| 19 |
31660824 | A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. | 2020 |
3 |
| 20 |
31702488 | Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool. | 2020 |
2 |
| 21 |
31836535 | Differential blockade by huperzine A and donepezil of sympathetic nicotinic acetylcholine receptor-mediated nitrergic neurogenic dilations in porcine basilar arteries. | 2020 Feb 5 |
1 |
| 22 |
32006676 | Correlation of plasma butyrylcholinesterase concentration with Acethylcholinesterase H353N polymorphism in the inflammatory response of Chagas disease patients. | 2020 Jun |
2 |
| 23 |
32048433 | Aporphinoid Alkaloids Derivatives as Selective Cholinesterases Inhibitors: Biological Evaluation and Docking Study. | 2020 Nov |
1 |
| 24 |
32326457 | Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease. | 2020 Apr 15 |
2 |
| 25 |
32344943 | Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone. | 2020 Apr 25 |
2 |
| 26 |
32650180 | Bioactivity and molecular docking studies of some nickel complexes: New analogues for the treatment of Alzheimer, glaucoma and epileptic diseases. | 2020 Aug |
3 |
| 27 |
32942070 | Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase. | 2020 Dec 1 |
1 |
| 28 |
30387392 | Drug Design of Inhibitors of Alzheimer's Disease (AD): POM and DFT Analyses of Cholinesterase Inhibitory Activity of β-amino di-Carbonyl Derivatives. | 2019 |
1 |
| 29 |
30974029 | Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease. | 2019 Aug |
1 |
| 30 |
31053120 | Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer's disease. | 2019 May 3 |
2 |
| 31 |
31064071 | Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease. | 2019 May 6 |
1 |
| 32 |
31158754 | Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease. | 2019 Sep 1 |
4 |
| 33 |
31201687 | Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias. | 2019 Aug |
1 |
| 34 |
31315410 | The Acetylcholine Therapy in the Treatment of Schizophrenia - The Experience of Mario Fiamberti in the Hospital of Varese (1937). | 2019 Jun |
1 |
| 35 |
31320703 | Bedside-measurement of serum cholinesterase activity predicts patient morbidity and length of the intensive care unit stay following major traumatic injury. | 2019 Jul 18 |
2 |
| 36 |
31382668 | Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors. | 2019 Aug 4 |
3 |
| 37 |
31561368 | Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology. | 2019 |
1 |
| 38 |
31601022 | Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could BCHE Genotyping Be Helpful in Alzheimer's Therapy? | 2019 Oct 9 |
2 |
| 39 |
31675671 | A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies. | 2019 Dec |
2 |
| 40 |
31708262 | Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening. | 2019 Dec 15 |
1 |
| 41 |
31888102 | Alzheimer's Disease Pharmacotherapy in Relation to Cholinergic System Involvement. | 2019 Dec 26 |
1 |
| 42 |
28714400 | Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site. | 2018 |
4 |
| 43 |
29243034 | Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series. | 2018 Apr |
1 |
| 44 |
29358722 | Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation. | 2018 Jan 22 |
1 |
| 45 |
29363680 | Assay of serum cholinesterase activity by an amperometric biosensor based on a co-crosslinked choline oxidase/overoxidized polypyrrole bilayer. | 2018 Feb 12 |
1 |
| 46 |
29473519 | Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies. | 2018 |
3 |
| 47 |
29535625 | Treating Cocaine Addiction, Obesity, and Emotional Disorders by Viral Gene Transfer of Butyrylcholinesterase. | 2018 |
2 |
| 48 |
29550345 | An improved immobilized enzyme reactor-mass spectrometry-based label free assay for butyrylcholinesterase ligand screening. | 2018 May 15 |
1 |
| 49 |
29803450 | Evaluation of butyrylcholinesterase inhibitory activity by chlorogenic acids and coffee extracts assed in ITC and docking simulation models. | 2018 Jul |
1 |
| 50 |
29850777 | The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. | 2018 Jul 1 |
1 |